Delcath Competitors
| DCTH Stock | USD 9.91 0.01 0.10% |
Delcath Systems vs Kindly MD Correlation
Very good diversification
The correlation between Delcath Systems and NAKA is -0.47 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Delcath Systems and NAKA in the same portfolio, assuming nothing else is changed.
Moving against Delcath Stock
| 0.77 | IHC | Inspiration Healthcare | PairCorr |
| 0.75 | 300869 | Contec Medical Systems | PairCorr |
| 0.65 | OTC | Ocumetics Technology Corp | PairCorr |
| 0.61 | 688198 | Beijing Balance Medical | PairCorr |
| 0.48 | 300981 | Zhonghong Pulin Medical | PairCorr |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Delcath Systems' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Delcath Systems Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Delcath Systems and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Delcath and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Delcath Systems does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Delcath Stock performing well and Delcath Systems Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Delcath Systems' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BWAY | 2.77 | 0.49 | 0.18 | 0.31 | 2.53 | 7.25 | 15.24 | |||
| TCMD | 2.67 | 1.08 | 0.61 | 1.81 | 1.07 | 7.40 | 46.16 | |||
| NPCE | 3.02 | 0.58 | 0.25 | 0.29 | 2.17 | 6.30 | 43.20 | |||
| RXST | 3.01 | 0.04 | 0.02 | 0.08 | 3.72 | 7.97 | 23.38 | |||
| CERS | 3.67 | 0.65 | 0.17 | 0.39 | 3.49 | 10.19 | 30.94 | |||
| SMLR | 49.98 | 23.87 | 4.11 | 0.89 | 4.86 | 18.45 | 1,670 | |||
| MASS | 3.06 | (0.34) | 0.00 | 1.27 | 0.00 | 6.91 | 23.15 | |||
| AGL | 4.59 | (0.20) | 0.00 | 0.00 | 0.00 | 10.00 | 30.19 | |||
| SENS | 3.24 | (0.09) | 0.00 | 0.02 | 4.29 | 6.74 | 18.36 | |||
| NAKA | 5.41 | (0.97) | 0.00 | (0.35) | 0.00 | 11.43 | 33.09 |
Cross Equities Net Income Analysis
Compare Delcath Systems and related stocks such as Brainsway, Tactile Systems Tech, and Neuropace Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BWAY | (5.9 M) | (5.9 M) | (5.9 M) | (7.1 M) | (6.5 M) | (4.1 M) | (2.4 M) | (7.1 M) | (6.5 M) | (10.3 M) | (5.4 M) | (6.5 M) | (13.3 M) | (4.2 M) | 2.9 M | 3.4 M | 3.5 M |
| TCMD | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 2.1 M | 1.4 M | 2.9 M | 5.9 M | 6.6 M | 11 M | (620 K) | (11.8 M) | (17.9 M) | 28.5 M | 17 M | 19.5 M | 20.5 M |
| NPCE | (30 M) | (30 M) | (30 M) | (30 M) | (30 M) | (30 M) | (30 M) | (30 M) | (30 M) | (30 M) | (24.3 M) | (36.1 M) | (47.1 M) | (33 M) | (27.1 M) | (24.4 M) | (25.6 M) |
| RXST | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 126.2 M | 27.6 M | (48.7 M) | (66.8 M) | (48.6 M) | (27.5 M) | (24.7 M) | (23.5 M) |
| CERS | (14.7 M) | (17 M) | (15.9 M) | (43.3 M) | (38.6 M) | (55.9 M) | (62.9 M) | (60.6 M) | (57.6 M) | (71.2 M) | (59.9 M) | (54.4 M) | (42.8 M) | (37.5 M) | (20.9 M) | (18.8 M) | (19.8 M) |
| MASS | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (7.5 M) | (13.4 M) | (12.8 M) | (22.2 M) | (31.7 M) | (36.4 M) | (72.2 M) | (65 M) | (61.7 M) |
| AGL | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (282.6 M) | (60.1 M) | (406.5 M) | (106.6 M) | (262.6 M) | (260.2 M) | (234.1 M) | (245.8 M) |
| SENS | (18.8 M) | (18.8 M) | (18.8 M) | (18.8 M) | (18.9 M) | (29.9 M) | (43.9 M) | (59.1 M) | (94 M) | (115.5 M) | (175.2 M) | (302.5 M) | 142.1 M | (60.4 M) | (78.6 M) | (70.8 M) | (74.3 M) |
| NAKA | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | 149.3 K | (2.5 M) | (1.6 M) | (3.6 M) | (3.3 M) | (3.1 M) |
Delcath Systems and related stocks such as Brainsway, Tactile Systems Tech, and Neuropace Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Delcath Systems financial statement analysis. It represents the amount of money remaining after all of Delcath Systems operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Delcath Systems Competitive Analysis
The better you understand Delcath Systems competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Delcath Systems' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Delcath Systems' competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Delcath Systems Competition Performance Charts
Five steps to successful analysis of Delcath Systems Competition
Delcath Systems' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Delcath Systems in relation to its competition. Delcath Systems' competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Delcath Systems in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Delcath Systems' competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Delcath Systems, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Delcath Systems position
In addition to having Delcath Systems in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Latest Losers Thematic Idea Now
Latest Losers
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Losers theme has 238 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Losers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Delcath Systems Correlation with its peers. For more detail on how to invest in Delcath Stock please use our How to Invest in Delcath Systems guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is there potential for Health Care Equipment & Supplies market expansion? Will Delcath introduce new products? Factors like these will boost the valuation of Delcath Systems. Projected growth potential of Delcath fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Delcath Systems listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.67) | Earnings Share 0.03 | Revenue Per Share | Quarterly Revenue Growth 0.836 | Return On Assets |
The market value of Delcath Systems is measured differently than its book value, which is the value of Delcath that is recorded on the company's balance sheet. Investors also form their own opinion of Delcath Systems' value that differs from its market value or its book value, called intrinsic value, which is Delcath Systems' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Delcath Systems' market value can be influenced by many factors that don't directly affect Delcath Systems' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Delcath Systems' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Delcath Systems should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Delcath Systems' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.